CAS 2411759-92-5

EZM0414 TFA

CAS : 2411759-92-5

EZM0414 TFA

Degré de pureté : ≥95%

Masse moléculaire : 514.51g/mol

Ref: 54-BUP21680

EZM0414 TFA

CAS : 2411759-92-5

EZM0414 TFA (SETD2-IN-1 TFA) is a SETD2 inhibitor with anticancer and antiproliferative effects for the study of leukemia and immune dysfunction.

Formule : C₂₄H₃₀F₄N₄O₄

Degré de pureté : 98.88%

Couleur et forme : Solid

Masse moléculaire : 514.51

Ref: TM-T36975

SETD2-IN-1 TFA

CAS : 2411759-92-5

SETD2-IN-1 TFA is a potent inhibitor of the kinase SETD2, which plays a key role in regulating gene expression and DNA damage response. This inhibitor has been shown to induce apoptosis in cancer cells, making it a promising candidate for anticancer therapy. SETD2-IN-1 TFA has also been detected in human urine and may have potential as a biomarker for cancer diagnosis or monitoring. In addition to its anticancer properties, this compound has been found to be an analog of oxytocin and caffeine, which suggests that it may have other physiological effects beyond its kinase inhibitory activity. Overall, SETD2-IN-1 TFA is a promising new tool for cancer research and drug development.

Formule : C₂₄H₃₀F₄N₄O₄

Degré de pureté : Min. 95%

Masse moléculaire : 514.5 g/mol

Ref: 3D-LWD75992